Sign in

CIK 0000899923

  • Accelerated filer

MYRIAD GENETICS INC

Sign in to watch
Ticker
MYGN
Exchange
Nasdaq
Industry
In Vitro & In Vivo Diagnostic Substances
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
870494517
Phone
+1 801-584-3600
Business address
322 NORTH 2200 WEST, SALT LAKE CITY, UT, 84116
Former names
MYRIAD GENETICS INC
  1. 4/A Insider Changes in Ownership
  2. 4 Returned to the company Chief Financial Officer returned 11,175 shares (to the company)
  3. 4 Grant or award SVP Enterprise Transformation acquired 30,000 shares (grant or award)
  4. 3 Insider Initial Statement of Ownership
  5. 4 Grant or award SVP Technology acquired 10,000 shares (grant or award)
  6. 3 Insider Initial Statement of Ownership
  7. 4 Open-market sale Chief Scientific Officer sold 80,000 shares at $29.71 ($2,377,048)
  8. 4 Open-market sale EVP Strategy and Innovation sold 11,824 shares at $25.00 ($295,600)
  9. 4 Grant or award Director acquired 15,889 shares (grant or award)
  10. 4 Grant or award Director acquired 15,889 shares (grant or award)
  11. 4 Grant or award Director acquired 15,889 shares (grant or award)
  12. 4 Grant or award Director acquired 15,889 shares (grant or award)
  13. 4 Grant or award Director acquired 15,889 shares (grant or award)
  14. 4 Grant or award Director acquired 15,889 shares (grant or award)
  15. 4 Grant or award Director acquired 15,889 shares (grant or award)
  16. 4 Open-market buy Director bought 15,000 shares at $16.62 ($249,336)
  17. 4 Returned to the company EVP Strategy and Innovation returned 2,218 shares (to the company)
  18. 4 Grant or award Executive VP Human Resources acquired 17,853 shares (grant or award)
  19. 4 Grant or award EVP Strategy and Innovation acquired 21,730 shares (grant or award)
  20. 4 Grant or award E.V.P., General Counsel acquired 29,784 shares (grant or award)

Page 20 of 65 · 1,294 filings